相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Engineering Electronic Band Structure of Binary Thermoelectric Nanocatalysts for Augmented Pyrocatalytic Tumor Nanotherapy
Yachao Wang et al.
ADVANCED MATERIALS (2022)
Antibody-drug conjugates: Smart chemotherapy delivery across tumor histologies
Paolo Tarantino et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy
Subhajit Chatterjee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
The biology and rationale of targeting nectin-4 in urothelial carcinoma
Elisabeth I. Heath et al.
NATURE REVIEWS UROLOGY (2021)
Combined Photothermotherapy and Chemotherapy of Oral Squamous Cell Carcinoma Guided by Multifunctional Nanomaterials Enhanced Photoacoustic Tomography
Sujuan Zeng et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy
Sofia Koustoulidou et al.
CANCERS (2021)
Radionuclide-Based Imaging of Breast Cancer: State of the Art
Huiling Li et al.
CANCERS (2021)
Biomimetic oxygen delivery nanoparticles for enhancing photodynamic therapy in triple-negative breast cancer
Hanyi Fang et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in glioma
Alexandra Foster et al.
EBIOMEDICINE (2021)
Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs
Qitong Wu et al.
CANCERS (2021)
Anti-CD47 Monoclonal Antibody-Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers
Yingnan Si et al.
VACCINES (2021)
A Novel Bispecific Antibody Targeting CD3 and Lewis Y with Potent Therapeutic Efficacy against Gastric Cancer
Jie Chen et al.
BIOMEDICINES (2021)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Antibody-Drug Conjugates in Urothelial Carcinomas
Michal Sarfaty et al.
CURRENT ONCOLOGY REPORTS (2020)
ImmunoPET: Concept, Design, and Applications
Weijun Wei et al.
CHEMICAL REVIEWS (2020)
Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders-An Update
Jonatan Dewulf et al.
CANCERS (2020)
Nanoformulated quinacrine regulates NECTIN-4 domain specific functions in cervical cancer stem cells
Subhajit Chatterjee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Recombinant SLAMblind Measles Virus Is a Promising Candidate for Nectin-4-Positive Triple Negative Breast Cancer Therapy
Tomoko Fujiyuki et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Mature results from EV-101: A phase I study of enfortumab vedotin in patients with metastatic urothelial cancer (mUC).
Jonathan E. Rosenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
CD146-Targeted Multimodal Image-Guided Photoimmunotherapy of Melanoma
Weijun Wei et al.
ADVANCED SCIENCE (2019)
Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients
Haifeng Deng et al.
CANCER CELL INTERNATIONAL (2019)
Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy
Jonathan E. Rosenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge
Milica Nedeljkovic et al.
CELLS (2019)
Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer
Jasmin Zeindler et al.
FRONTIERS IN MEDICINE (2019)
Nectin-4 promotes gastric cancer progression via the PI3K/AKT signaling pathway
Yan Zhang et al.
HUMAN PATHOLOGY (2018)
Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study
Weikai Xiao et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer
M. M-Rabet et al.
ANNALS OF ONCOLOGY (2017)
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
Xiaoxian Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Beyond the margins: real-time detection of cancer using targeted fluorophores
Ray R. Zhang et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Indocyanine green fluorescence imaging in colorectal surgery: overview, applications, and future directions
Deborah S. Keller et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Indocyanine green delivery systems for tumour detection and treatments
Elena P. Porcu et al.
BIOTECHNOLOGY ADVANCES (2016)
Preclinical Evaluation of an Anti-Nectin-4 ImmunoPET Reagent in Tumor-Bearing Mice and Biodistribution Studies in Cynomolgus Monkeys
Dean O. Campbell et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Nectin-4 expression contributes to tumor proliferation, angiogenesis and patient prognosis in human pancreatic cancer
Satoshi Nishiwada et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Indium-111-labeled Girentuximab ImmunoSPECT as a Diagnostic Tool in Clear Cell Renal Cell Carcinoma
Constantijn H. J. Muselaers et al.
EUROPEAN UROLOGY (2013)
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up
L. Malorni et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
A Potencial Theranostic Agent for EGF-R Expression Tumors: 177Lu-DOTA-Nimotuzumab
Victoria Calzada et al.
CURRENT RADIOPHARMACEUTICALS (2012)
Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules
Makoto Mitsunaga et al.
NATURE MEDICINE (2011)
Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients
Xiaosong Li et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2011)
Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody
Weibo Cai et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Prognostic markers in triple-negative breast cancer
Emad A. Rakha et al.
CANCER (2007)
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
Bruce G. Haffty et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Indocyanine green nanoparticles useful for photomedicine
Anderson J. Gomes et al.
PHOTOMEDICINE AND LASER SURGERY (2006)
Prominent role of the Ig-like V domain in trans-interactions of nectins -: Nectin3 and nectin4 bind to the predicted C-C′-C-D β-strands of the nectin1 V domain
S Fabre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with Nectin1/PRR1 through V domain interaction
N Reymond et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)